Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Principles of Drug Action

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting the Crosstalk Between Metabolism and Chronic Inflammation: In Silico Multitargeting Drug Design Approach for Cardiometabolic Syndrome.

Biomedicines·2026

Same author

Advancing Accurate Quantification of Protein-Ligand Interactions: Differential Scanning Calorimetry as a Precision Screening Tool Using BCL-2 as a Model System.

ChemMedChem·2026

Same author

Correction: Petsas et al. Protein-Ligand Interactions in Cardiometabolic Drug Targets: Focus on Weight Loss and Cardioprotection. <i>Molecules</i> 2025, <i>30</i>, 4240.

Molecules (Basel, Switzerland)·2026

Same author

Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024).

Biomolecules·2026

Same author

Isolation and Biophysical Characterization of Lipoxygenase-1 from Soybean Seed, a Versatile Biocatalyst for Industrial Applications.

Biomolecules·2026

Same author

Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "<i>The Rule of Four for Inflammation</i>".

Life (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: Jul 7, 2025

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

Quercetin: A Potential Polydynamic Drug.

Nikitas Georgiou¹, Margarita Georgia Kakava², Efthymios Alexandros Routsi^1,3

¹Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.

Molecules (Basel, Switzerland)

|December 23, 2023

Summary

Quercetin, a natural flavonoid, offers anti-cancer and anti-inflammatory benefits. Encapsulating quercetin in macromolecules enhances its bioavailability and pharmaceutical efficiency for drug development.

Keywords:

flavonoids quercetin

More Related Videos

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

Related Experiment Videos

Last Updated: Jul 7, 2025

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

Area of Science:

Pharmacology and Natural Products Chemistry
Drug Delivery Systems
Nanotechnology in Medicine

Background:

Natural products, particularly flavonoids like quercetin, are extensively researched as potential therapeutic agents.
Quercetin exhibits significant anti-cancer, anti-inflammatory, and antimicrobial properties.
A major limitation of quercetin is its poor bioavailability and low solubility, hindering its pharmaceutical application.

Purpose of the Study:

To review the beneficial pharmaceutical effects of quercetin.
To discuss the challenges associated with quercetin's bioavailability and solubility.
To explore encapsulation strategies, including novel nanotechnological approaches, to enhance quercetin's efficacy.

Main Methods:

Literature review of quercetin's pharmacological activities.
Analysis of existing encapsulation techniques for quercetin.
Proposal and discussion of new encapsulation methods utilizing nanotechnology.

Main Results:

Quercetin demonstrates a wide range of beneficial bioactivities, including anti-cancer, anti-inflammatory, and antimicrobial effects.
Macromolecular encapsulation significantly improves quercetin's bioavailability and solubility.
Nanotechnology-based delivery systems offer promising avenues for enhanced quercetin pharmaceutical efficiency.

Conclusions:

Quercetin is a promising natural compound with diverse therapeutic potentials.
Overcoming poor bioavailability through advanced encapsulation techniques is crucial for realizing quercetin's full pharmaceutical value.
Novel nanocarrier systems represent a significant advancement in optimizing quercetin-based drug delivery and efficacy.